Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

BACKGROUND: We investigated the potential associations between cerebro-spinal fluid (CSF) levels of phosphorylated tau (P-tau) and total tau (T-tau) with short-term response to cholinesterase inhibitor (ChEI) treatment, longitudinal outcome and progression rates in Alzheimer’s disease (AD). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wattmo, Carina, Blennow, Kaj, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951013/
https://www.ncbi.nlm.nih.gov/pubmed/31918679
http://dx.doi.org/10.1186/s12883-019-1591-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951013/
https://www.ncbi.nlm.nih.gov/pubmed/31918679
http://dx.doi.org/10.1186/s12883-019-1591-0

Ejemplares similares